Protagenic Therapeutics, Inc.new (PTIX) Cash & Current Investments (2009 - 2026)
Protagenic Therapeutics, Inc.new's Cash & Current Investments came in at $76,909 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 97.2% from $2.72 million a year earlier and down 86.4% from the prior quarter.
Protagenic Therapeutics, Inc.new (PTIX) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.new's Cash & Current Investments was $1.51 million.
- Cash & Current Investments carries a five-year compound annual growth rate of -32.0% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Current Investments was $14,531 in FY2025, $79,568 in FY2024 (-98.0%), $4.06 million in FY2023 (-49.2%) and $7.98 million in FY2022 (-23.1%).
- The fiscal Q2 2027 figure represents the lowest quarterly Cash & Current Investments since fiscal Q4 2025.
- Business Quant data shows PTIX's Cash & Current Investments at $565,985 (Q1 2027), $1.51 million (Q4 2026) and $2.21 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 7.96 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -4.70 Mn | - | 310,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 76,909.00 |
| Jun 30, 2026 | 565,985.00 |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 14,531.00 |
| Dec 31, 2024 | 79,568.00 |
| Sep 30, 2024 | 71,396.00 |
| Jun 30, 2024 | 924,596.00 |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 4.06 Mn |
| Sep 30, 2023 | 5.27 Mn |
| Jun 30, 2023 | 6.04 Mn |
| Mar 31, 2023 | 7.65 Mn |
| Dec 31, 2022 | 7.98 Mn |
| Sep 30, 2022 | 8.15 Mn |
| Jun 30, 2022 | 8.87 Mn |
| Mar 31, 2022 | 9.79 Mn |
| Dec 31, 2021 | 10.37 Mn |
| Sep 30, 2021 | 10.85 Mn |
Protagenic Therapeutics, Inc.new Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();